Cidara Therapeutics, Inc. passed rezafungin rights to Mundipharma allowing reallocation of resources to the oncology Cloudbreak platform.Following a considerable private placement and re-acquisition ...
Source LinkCidara Therapeutics, Inc. passed rezafungin rights to Mundipharma allowing reallocation of resources to the oncology Cloudbreak platform.Following a considerable private placement and re-acquisition ...
Source Link
Comments